Lisa Boris
Overview
Explore the profile of Lisa Boris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
329
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
King A, Roche K, Vera E, Pillai V, Polskin L, Acquaye-Mallory A, et al.
Neurooncol Pract
. 2025 Feb;
12(1):76-86.
PMID: 39917751
Background: This study explored differences in patient-reported outcomes (PROs) for patients with central nervous system (CNS) tumors during COVID, compared to pre-pandemic assessments, in light of impacted access to in-person...
2.
Pascoe M, Wollet A, De La Cruz Minyety J, Vera E, Miller H, Celiku O, et al.
Neurooncol Pract
. 2024 Sep;
11(5):640-651.
PMID: 39279778
Background: Sleep-wake disturbances are common and disabling in primary brain tumor (PBT) patients but studies exploring longitudinal data are limited. This study investigates the feasibility and relationship between longitudinal patient-reported...
3.
Burton E, Ozer B, Boris L, Brown D, Theeler B
Adv Oncol
. 2024 Jun;
4(1):101-110.
PMID: 38868646
No abstract available.
4.
Rogers J, Wall T, Acquaye-Mallory A, Boris L, Kim Y, Aldape K, et al.
J Neurooncol
. 2024 Mar;
167(2):349-359.
PMID: 38427131
Purpose: Multidisciplinary tumor boards (MTBs) integrate clinical, molecular, and radiological information and facilitate coordination of neuro-oncology care. During the COVID-19 pandemic, our MTB transitioned to a virtual and multi-institutional format....
5.
Briceno N, Vera E, Komlodi-Pasztor E, Abdullaev Z, Choi A, Grajkowska E, et al.
Neurooncol Adv
. 2024 Feb;
6(1):vdae019.
PMID: 38420614
Background: Glioblastoma (GBM) is the most aggressive primary brain malignancy with <45% living a year beyond diagnosis. Previously published investigations of long-term survivors (LTS) provided clinical data but rarely incorporated...
6.
King A, Roche K, Leeper H, Vera E, Mendoza T, Mentges K, et al.
J Neurooncol
. 2023 Mar;
162(1):137-145.
PMID: 36884201
Purpose: Cancer patients experience distress and anxiety when undergoing imaging studies to monitor disease status, yet these symptoms are not always appropriately identified or well-managed. This interim analysis of a...
7.
Bergsneider B, Vera E, Gal O, Christ A, King A, Acquaye A, et al.
Neurooncol Adv
. 2023 Feb;
5(1):vdac188.
PMID: 36820236
Background: Precision health approaches to managing symptom burden in primary brain tumor (PBT) patients are imperative to improving patient outcomes and quality of life, but require tackling the complexity and...
8.
King A, Roche K, Leeper H, Vera E, Mendoza T, Mentges K, et al.
Res Sq
. 2023 Feb;
PMID: 36789426
Cancer patients experience distress and anxiety when undergoing imaging studies to monitor disease status, yet these symptoms are not always appropriately identified or well-managed. This interim analysis of a phase...
9.
Leeper H, Vera E, Christ A, Acquaye A, Briceno N, Choi A, et al.
Neurology
. 2023 Feb;
100(16):e1723-e1736.
PMID: 36754634
Background And Objectives: Financial toxicity significantly affects many patients, especially cancer survivors. We evaluated the association of unemployment as a major contributor to financial toxicity with patient-reported outcomes (PROs) assessing...
10.
Frederico S, Vera E, Abdullaev Z, Acquaye A, Aldape K, Boris L, et al.
Front Oncol
. 2023 Feb;
13:1099618.
PMID: 36741001
The uncommon -altered primary central nervous system (CNS) tumors were recently added to the World Health Organization 2021 classification under the name Astroblastoma, -altered. Another term used to describe them,...